Savant Capital’s Insmed INSM Stock Holding History

Savant Capital’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,789	Closed	-$293K	–	1889
2026 Q1	$293K	Buy	1,789 +142	+9%	+$21.8K	﹤0.01%	1187
2025 Q4	$287K	Sell	1,647 -81	-5%	-$14.8K	﹤0.01%	1078
2025 Q3	$249K	Buy	+1,728	New	+$212K	﹤0.01%	1127

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Savant Capital's INSM Position: Q2 2026 in Review

Savant Capital sold out of Insmed (INSM) in Q2 2026, closing a stake of 1,789 shares — an estimated $293K sold.

Savant Capital first reported a position in INSM in Q3 2025 and held it in 3 quarters. The position peaked at $293K in Q1 2026. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Savant Capital reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
Savant Capital sold 1,789 Insmed shares in Q2 2026, an estimated $293K.
Savant Capital first reported a position in Insmed in Q3 2025 and held it in 3 quarters.
Savant Capital's Insmed position peaked at $293K in Q1 2026.
663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.